CCDA Selective Supplement

Hazard statements (CLP)

H317, H334, H373

Code

Statements

H317

May cause an allergic skin reaction

CLP CLASSIFICATION

Respiratory sensitization (Category 1), H334 Skin sensitization (Category 1), H317 Specific target organ toxicity - repeated exposure (Category 2), H373 For the full text of the H-Statements mentioned in this Section, see Section 16.

2.2 Label elements

Labelling according Regulation (EC) No 1272/2008

Signal word

Danger Danger

Hazard statements

H317 May cause an allergic skin reaction. H334 May cause allergy or asthma symptoms or breathing difficulties if inhaled. H373 May cause damage to organs through prolonged or repeated exposure. Reduced Labeling (<= 125 ml) H334 May cause allergy or asthma symptoms or breathing difficulties if inhaled. H317 May cause an allergic skin reaction.

Precautionary statements

P260 Do not breathe dust/ fume/ gas/ mist/ vapors/ spray. P272 Contaminated work clothing should not be allowed out of the workplace. P280 Wear protective gloves. P284 Wear respiratory protection. P302 + P352 IF ON SKIN: Wash with plenty of water. P333 + P313 If skin irritation or rash occurs: Get medical advice/ attention. P272 Contaminated work clothing should not be allowed out of the workplace. P280 Wear protective gloves. P284 Wear respiratory protection. P302 + P352 IF ON SKIN: Wash with plenty of water. P333 + P313 If skin irritation or rash occurs: Get medical advice/ attention.

Supplemental label elements

none none

2.3 Other hazards

This substance/mixture contains no components considered to be either persistent, bioaccumulative and toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher. Caution: Physiologically highly active, therapeutically usable substance. The substance must be handled with the care required for hazardous materials.